Trulieve Cannabis Corp. (TRLV) stock
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.07−0.26 (-2.52%)
Close on Nov 17, 2026Market cap $1.94BP/E –Yield –
Trulieve Cannabis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Trulieve Cannabis's operating cash flow for the twelve months ending Jun 30, 2026 was $244.44M, up 23.3% year over year. For fiscal 2025 it was $272.82M, up 0.5% from the year before. The highest annual figure on record is $272.82M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $272.82M | +0.5% |
| FY2024 | Dec 31, 2024 | $271.48M | +34.5% |
| FY2023 | Dec 31, 2023 | $201.84M | +773.9% |
| FY2022 | Dec 31, 2022 | $23.10M | +79.1% |
| FY2021 | Dec 31, 2021 | $12.90M | -87.1% |
| FY2020 | Dec 31, 2020 | $99.64M | +422.4% |
| FY2019 | Dec 31, 2019 | $19.07M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $53.14M | -38.3% |
| Q1 FY2026 | Mar 31, 2026 | $55.71M | +9.0% |
| Q4 FY2025 | Dec 31, 2025 | $59.22M | +93.0% |
| Q3 FY2025 | Sep 30, 2025 | $76.38M | +151.8% |
| Q2 FY2025 | Jun 30, 2025 | $86.10M | +20.7% |
| Q1 FY2025 | Mar 31, 2025 | $51.13M | -63.3% |
| Q4 FY2024 | Dec 31, 2024 | $30.68M | -76.7% |
| Q3 FY2024 | Sep 30, 2024 | $30.34M | -67.5% |
| Q2 FY2024 | Jun 30, 2024 | $71.32M | – |
| Q1 FY2024 | Mar 31, 2024 | $139.15M | +33840.0% |
| Q4 FY2023 | Dec 31, 2023 | $131.46M | +139.0% |
| Q3 FY2023 | Sep 30, 2023 | $93.44M | – |
| Q2 FY2023 | Jun 30, 2023 | -$23.47M | – |
| Q1 FY2023 | Mar 31, 2023 | $410.00K | -99.1% |
| Q4 FY2022 | Dec 31, 2022 | $55.01M | – |
| Q3 FY2022 | Sep 30, 2022 | -$21.63M | -183.6% |
| Q2 FY2022 | Jun 30, 2022 | -$55.43M | – |
| Q1 FY2022 | Mar 31, 2022 | $45.15M | -24.2% |
| Q4 FY2021 | Dec 31, 2021 | -$62.18M | -332.0% |
| Q3 FY2021 | Sep 30, 2021 | $25.89M | – |
| Q2 FY2021 | Jun 30, 2021 | -$10.40M | -119.3% |
| Q1 FY2021 | Mar 31, 2021 | $59.59M | +149.1% |
| Q4 FY2020 | Dec 31, 2020 | $26.80M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.83M | – |
| Q2 FY2020 | Jun 30, 2020 | $53.75M | – |
| Q1 FY2020 | Mar 31, 2020 | $23.92M | – |
See a number that looks wrong?